| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +66.67% | +2.19% | -1.26% | +3.46% | +4.36% | — |
| 14d | 3 | +66.67% | +6.49% | -1.71% | +8.20% | +9.91% | — |
| 30d | 3 | +33.33% | +21.15% | +4.81% | +16.34% | +12.60% | — |
| 60d | 3 | +33.33% | +30.54% | +9.78% | +20.76% | +2.70% | — |
| 90d | 3 | +33.33% | +35.53% | +12.02% | +23.51% | +35.95% | — |
| 180d | 3(1 pending) | +50.00% | +72.04% | +19.26% | +52.78% | +52.78% | — |
| 1y | 3(1 pending) | +50.00% | +45.93% | +22.20% | +29.39% | +29.39% | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CRSP CRISPR THERAPEUTICS AG | SALE Chief Medical Officer | 3,786 | $55.62 | $210.6K | 19,357 | May 29, 2026 | Jun 1, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 22,000 | — | — | 22,000 | May 29, 2026 | Jun 2, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE Chief Medical Officer | 10,000 | — | — | 20,000 | May 28, 2026 | Jun 1, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE Chief Medical Officer | 10,000 | — | — | 23,143 | May 28, 2026 | Jun 1, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 38,499 | — | — | 38,499 | Mar 20, 2026 | Mar 24, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Mar 20, 2026 | Mar 24, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE Chief Medical Officer | 3,150 | $48.26 | $152.0K | 13,143 | Mar 16, 2026 | Mar 17, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE Chief Medical Officer | 8,125 | — | — | 24,375 | Mar 14, 2026 | Mar 17, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE Chief Medical Officer | 8,125 | — | — | 16,293 | Mar 14, 2026 | Mar 17, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 16,500 | — | — | 16,500 | Oct 3, 2025 | Oct 3, 2025 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | May 30, 2025 | Jun 3, 2025 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE Chief Medical Officer | 3,932 | $35.94 | $141.3K | 6,068 | May 29, 2025 | May 30, 2025 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE Chief Medical Officer | 10,000 | — | — | 10,000 | May 28, 2025 | May 30, 2025 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE Chief Medical Officer | 10,000 | — | — | 30,000 | May 28, 2025 | May 30, 2025 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE Chief Medical Officer | 1,508 | $32.96 | $49.7K | 1,508 | Apr 3, 2025 | Jan 27, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 32,500 | — | — | 32,500 | Mar 14, 2025 | Mar 18, 2025 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 46,667 | — | — | 46,667 | Mar 14, 2025 | Mar 18, 2025 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 18,333 | — | — | 18,333 | Oct 16, 2024 | Oct 18, 2024 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 85,000 | — | — | 85,000 | May 28, 2024 | May 29, 2024 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | May 28, 2024 | May 29, 2024 ↗ | View → |